Enlaza Therapeutics
Founded 2021 · $161.0M raised
- Founded
- 2021
- Business Model
- B2B
- Website
- enlazatx.com
- Total Funding
- $161.0M
- Last Round
- $100.0M Series AApr 2024
- Rounds
- 2
About
Biotech company pioneering covalent biologics — novel protein therapeutics with improved efficacy and safety profiles.
Summary
Enlaza Therapeutics is a Biotech company, founded in 2021. It has raised $161.0M in total across 2 rounds, most recently a $100.0M Series A round in Apr 2024. Investors include J.P. Morgan Asset Management, Avalon Ventures and Amgen.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company